What does Apotheek Fien Clarysse do?

Apotheek Fien Clarysse is a pharmacy in Leuven. Private Limited, started on 22 December 1988, 1 establishment.

What is the address of Apotheek Fien Clarysse?

The registered office of Apotheek Fien Clarysse is located at Kapucijnenvoer 108, 3000 Leuven.

Is Apotheek Fien Clarysse still active?

Yes. According to the CBE (2 November 2026) Apotheek Fien Clarysse is active, legal situation “Normale toestand”, started on 22 December 1988.

Is Apotheek Fien Clarysse registered on Peppol?

Yes, Apotheek Fien Clarysse is registered on the Peppol network with ID 0208:0436363705.

What is the enterprise number of Apotheek Fien Clarysse?

The enterprise number of Apotheek Fien Clarysse is BE0436363705.

When was Apotheek Fien Clarysse founded?

Apotheek Fien Clarysse was founded on 22 December 1988.

Who are the directors of Apotheek Fien Clarysse?

According to the 2025 annual accounts, the directors of Apotheek Fien Clarysse are: FCL Pharma BV.

Is Apotheek Fien Clarysse a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Fien Clarysse make in 2025?

Apotheek Fien Clarysse posted a profit after taxes of € 14,707 in financial year 2025.

What is the revenue of Apotheek Fien Clarysse?

As a small company, Apotheek Fien Clarysse is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,845.

Apotheek Fien Clarysse (Private Limited) - Leuven

Dossier Apotheek Fien Clarysse, printed on 2 November 2026 from databakkes.be/en/0436363705/apotheek-fien-clarysse. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Fien Clarysse from Leuven, company number BE0436363705, closed financial year 2025 with a result of € 14,707 after tax. For that financial year Apotheek Fien Clarysse recorded a gross margin of € 19,845 and equity of € 243,436. Compared with financial year 2024, the result moved from € 2,965 to € 14,707. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 29, 2026.

What it is worth Growing

€ 243,436

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 14,707

▲ € 11,742 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 213,255

▼ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 224,836.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 156,878

▲ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,735

▲ 280% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 33,087 Gross margin 2022: € 33,087 First fiscal year in the series	€ 7,623 Gross margin 2023: € 7,623 ▼ 77% vs 2022 (€ 33,087) Unfavourable step	€ 6,247 Gross margin 2024: € 6,247 ▼ 18% vs 2023 (€ 7,623) Unfavourable step	€ 19,845 Gross margin 2025: € 19,845 ▲ 218% vs 2024 (€ 6,247) Favourable step	▲ 218%
Profit after taxes	€ 23,304 Profit after taxes 2022: € 23,304 First fiscal year in the series	€ 3,327 Profit after taxes 2023: € 3,327 ▼ 86% vs 2022 (€ 23,304) Unfavourable step	€ 2,965 Profit after taxes 2024: € 2,965 ▼ 11% vs 2023 (€ 3,327) Unfavourable step	€ 14,707 Profit after taxes 2025: € 14,707 ▲ € 11,742 vs 2024 (€ 2,965) Favourable step	▲ € 11,742
Equity	€ 222,436 Equity 2022: € 222,436 First fiscal year in the series	€ 225,763 Equity 2023: € 225,763 ▲ 1% vs 2022 (€ 222,436) Favourable step	€ 228,728 Equity 2024: € 228,728 ▲ 1% vs 2023 (€ 225,763) Favourable step	€ 243,436 Equity 2025: € 243,436 ▲ 6% vs 2024 (€ 228,728) Favourable step	▲ 6%
Total debts	€ 94,483 Total debts 2022: € 94,483 First fiscal year in the series	€ 87,864 Total debts 2023: € 87,864 ▼ 7% vs 2022 (€ 94,483) Favourable step	€ 137,814 Total debts 2024: € 137,814 ▲ 57% vs 2023 (€ 87,864) Unfavourable step	€ 162,045 Total debts 2025: € 162,045 ▲ 18% vs 2024 (€ 137,814) Unfavourable step	▲ 18%
Cash	€ 209,762 Cash 2022: € 209,762 First fiscal year in the series	€ 192,442 Cash 2023: € 192,442 ▼ 8% vs 2022 (€ 209,762) Unfavourable step	€ 235,328 Cash 2024: € 235,328 ▲ 22% vs 2023 (€ 192,442) Favourable step	€ 213,255 Cash 2025: € 213,255 ▼ 9% vs 2024 (€ 235,328) Unfavourable step	▼ 9%
Retained profit	€ 203,836 Retained profit 2022: € 203,836 First fiscal year in the series	€ 207,163 Retained profit 2023: € 207,163 ▲ 2% vs 2022 (€ 203,836) Favourable step	€ 210,128 Retained profit 2024: € 210,128 ▲ 1% vs 2023 (€ 207,163) Favourable step	€ 224,836 Retained profit 2025: € 224,836 ▲ 7% vs 2024 (€ 210,128) Favourable step	▲ 7%
Balance sheet total	€ 316,919 Balance sheet total 2022: € 316,919 First fiscal year in the series	€ 313,627 Balance sheet total 2023: € 313,627 ▼ 1% vs 2022 (€ 316,919) Unchanged	€ 366,543 Balance sheet total 2024: € 366,543 ▲ 17% vs 2023 (€ 313,627) Unchanged	€ 405,481 Balance sheet total 2025: € 405,481 ▲ 11% vs 2024 (€ 366,543) Unchanged	▲ 11%

Key figures of Apotheek Fien Clarysse, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Apotheek Fien Clarysse?

What happened at Apotheek Fien Clarysse in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 29, 2026 New annual accounts for financial year 2025: profit of € 14,707 (▲ € 11,742 vs 2024). Source: NBB ↗
Feb 21, 1989 New establishment in Leuven. KBO
Dec 22, 1988 Start of the company according to the CBE. KBO

In short

From € 23,304 profit in 2022 to € 14,707 profit in 2025.

Paid € 16,082 in corporate taxes since 2022.

Best year ever: 2022, with € 23,304 profit.

Original PDFs at the National Bank ↗

Management

FCL Pharma 99.6%

The stake of FCL Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Fien Clarysse

Behind Apotheek Fien Clarysse is FCL Pharma BV. The shares are held by FCL Pharma (99.6%).

Directors

According to the 2025 annual accounts

FCL Pharma BV

Director · represented by Fien Clarysse

Shareholders

FCL Pharma

99.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kapucijnenvoer 108

3000 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0436.363.705

VAT number

BE 0436.363.705

Registered office

Kapucijnenvoer 108, 3000 Leuven

Names & denominations

Apotheek Fien Clarysse

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 December 1988

Peppol

Active · Active since 30 Jan 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Fien Clarysse

Financials

What happened to Apotheek Fien Clarysse?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions